Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 6/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 6/20 | 0.49 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30170355 | 0.81 | SLC1A3 (0.39) | SLC1A3SLC1A2SLC1A1CNR2 | |
| SCHEMBL13501749 | 0.80 | CNR2 (0.39) | SLC1A3SLC1A2SLC1A1CNR2 | |
| SCHEMBL13435110 | 0.79 | SLC1A3 (0.37) | SLC1A3SLC1A2SLC1A1CNR2KMT2A | |
| SCHEMBL23289844 | 0.79 | PTGIR (0.59) | — | |
| SCHEMBL2377561 | 0.79 | ALDH1A1 (0.39) | KMT2A | |
| SCHEMBL13499740 | 0.78 | SLC1A3 (0.36) | SLC1A3SLC1A2SLC1A1CNR2CTSS | |
| SCHEMBL13461495 | 0.78 | SLC1A3 (0.36) | SLC1A3SLC1A2SLC1A1CNR2CTSS | |
| SCHEMBL19715260 | 0.76 | BCHE (0.48) | KMT2A | |
| SCHEMBL13501743 | 0.74 | SLC1A3 (0.41) | SLC1A3SLC1A2SLC1A1CNR2CTSS | |
| SCHEMBL19119024 | 0.74 | SLC1A3 (0.53) | SLC1A3SLC1A2SLC1A1TP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118159548-A | Antiviral compounds | 安力高医药股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| EP-4366831-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023283256-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2023-01-12 | — | — | WO | disclosed |